Skip to main content
OpenTrials
Completed

NCT Number: NCT02612974

Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis

This study has been designed to conduct as Randomized comparative clinical study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

About this study

Two groups, group B received Qurse Mafasil tablet orally two tablets two times daily for 8 weeks while group A received Leech therapy once weekly for 8 weeks along with Qurse mafasil.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • knee osteoarthritis

Exclusion criteria

  • pregnancy,
  • lactation,
  • anaemia

Treatment and study plan

Hirudinaria granulosa, qurse mafasil

Biological

compare the efficacy of both groups

Other names: leech and drug

Primary outcomes

  1. KOOS Score

    Time frame: end of 6 weeks

  2. VAS

    Time frame: end of 6 weeks

  3. Active Range of Motion

    Time frame: end of 6 weeks

  4. Knee circumference

    Time frame: end of 6 weeks

  5. 15 m walking time test

    Time frame: end of 6 weeks

Secondary outcomes

  1. KOOS subscores

    Time frame: end of 6 weeks

Sponsors and collaborators

Lead sponsor

Hamdard University

Other

Registry information

Official study title

Randomized Controlled Clinical Evaluation of Leech Therapy in the Treatment of Knee Osteoarthritis

Acronym: Leech Therapy

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Nov 24, 2015
Registry last updated
Nov 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.